Cargando…
Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro
Danggui Buxue Tang (DBT), a traditional Chinese Medicine decoction containing Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), is commonly prescribed for women in China as a remedy for menopausal symptoms. Previous study indicated that DBT stimulated cell growth and differentiation of human...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099153/ https://www.ncbi.nlm.nih.gov/pubmed/30150931 http://dx.doi.org/10.3389/fphar.2018.00779 |
_version_ | 1783348605296312320 |
---|---|
author | Zhou, Li-Ping Wong, Ka-Ying Yeung, Hoi-Ting Dong, Xiao-Li Xiao, Hui-Hui Gong, Amy G.-W. Tsim, Karl W.-K. Wong, Man-Sau |
author_facet | Zhou, Li-Ping Wong, Ka-Ying Yeung, Hoi-Ting Dong, Xiao-Li Xiao, Hui-Hui Gong, Amy G.-W. Tsim, Karl W.-K. Wong, Man-Sau |
author_sort | Zhou, Li-Ping |
collection | PubMed |
description | Danggui Buxue Tang (DBT), a traditional Chinese Medicine decoction containing Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), is commonly prescribed for women in China as a remedy for menopausal symptoms. Previous study indicated that DBT stimulated cell growth and differentiation of human osteosarcoma MG-63 cells and exhibited estrogenic properties via estrogen receptors (ERs). The present study aimed to study the bone protective effects of DBT and its potential interactions with selective estrogen receptor modulators (SERMs, tamoxifen and raloxifene) in both in vivo and in vitro models as they act via similar ERs. Six-month-old Sprague-Dawley rats were randomly assigned to the following treatments for 12 weeks: (1) sham-operated control group with vehicle (sham), (2) ovariectomized group with vehicle (OVX), (3) OVX with 17β-estradiol (E2, 2.0 mg/kg day), (4) OVX with tamoxifen (Tamo, 1.0 mg/kg day), (5) OVX with raloxifene (Ralo, 3.0 mg/kg day), (6) OVX with DBT (DBT, 3.0 g/kg day), (7) OVX with DBT+Tamoxifen (DBT+Tamo), and (8) OVX with DBT+Raloxifene (DBT+Ralo). Effects of DBT and potential interactions between DBT and SERMs were also evaluated in MG-63 cells. DBT, tamoxifen, raloxifene, and their combinations significantly increased bone mineral density (BMD) and improved trabecular bone properties, including bone surface (BS), trabecular bone number (Tb.N), and trabecular bone separation (Tb.Sp), as well as restored changes in bone turnover biomarkers and mRNA expression of genes involved in bone metabolism in OVX rats. Furthermore, DBT, SERMs, and their combinations significantly increased serum estradiol and suppressed follicle stimulating hormone and luteinizing hormone in OVX rats, suggesting the possible involvement of the hypothalamus–pituitary–gonadal axis in mediating their bone protective effects. However, SERMs, but not DBT, significantly increased uterus index in OVX rats. DBT significantly induced ALP activity and estrogen response element-dependent transcription in MG-63 cells. Our study demonstrated that DBT alone and in combinations with SERMs could exert bone protective effects in vitro and in vivo. |
format | Online Article Text |
id | pubmed-6099153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60991532018-08-27 Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro Zhou, Li-Ping Wong, Ka-Ying Yeung, Hoi-Ting Dong, Xiao-Li Xiao, Hui-Hui Gong, Amy G.-W. Tsim, Karl W.-K. Wong, Man-Sau Front Pharmacol Pharmacology Danggui Buxue Tang (DBT), a traditional Chinese Medicine decoction containing Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), is commonly prescribed for women in China as a remedy for menopausal symptoms. Previous study indicated that DBT stimulated cell growth and differentiation of human osteosarcoma MG-63 cells and exhibited estrogenic properties via estrogen receptors (ERs). The present study aimed to study the bone protective effects of DBT and its potential interactions with selective estrogen receptor modulators (SERMs, tamoxifen and raloxifene) in both in vivo and in vitro models as they act via similar ERs. Six-month-old Sprague-Dawley rats were randomly assigned to the following treatments for 12 weeks: (1) sham-operated control group with vehicle (sham), (2) ovariectomized group with vehicle (OVX), (3) OVX with 17β-estradiol (E2, 2.0 mg/kg day), (4) OVX with tamoxifen (Tamo, 1.0 mg/kg day), (5) OVX with raloxifene (Ralo, 3.0 mg/kg day), (6) OVX with DBT (DBT, 3.0 g/kg day), (7) OVX with DBT+Tamoxifen (DBT+Tamo), and (8) OVX with DBT+Raloxifene (DBT+Ralo). Effects of DBT and potential interactions between DBT and SERMs were also evaluated in MG-63 cells. DBT, tamoxifen, raloxifene, and their combinations significantly increased bone mineral density (BMD) and improved trabecular bone properties, including bone surface (BS), trabecular bone number (Tb.N), and trabecular bone separation (Tb.Sp), as well as restored changes in bone turnover biomarkers and mRNA expression of genes involved in bone metabolism in OVX rats. Furthermore, DBT, SERMs, and their combinations significantly increased serum estradiol and suppressed follicle stimulating hormone and luteinizing hormone in OVX rats, suggesting the possible involvement of the hypothalamus–pituitary–gonadal axis in mediating their bone protective effects. However, SERMs, but not DBT, significantly increased uterus index in OVX rats. DBT significantly induced ALP activity and estrogen response element-dependent transcription in MG-63 cells. Our study demonstrated that DBT alone and in combinations with SERMs could exert bone protective effects in vitro and in vivo. Frontiers Media S.A. 2018-08-13 /pmc/articles/PMC6099153/ /pubmed/30150931 http://dx.doi.org/10.3389/fphar.2018.00779 Text en Copyright © 2018 Zhou, Wong, Yeung, Dong, Xiao, Gong, Tsim and Wong. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhou, Li-Ping Wong, Ka-Ying Yeung, Hoi-Ting Dong, Xiao-Li Xiao, Hui-Hui Gong, Amy G.-W. Tsim, Karl W.-K. Wong, Man-Sau Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title | Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title_full | Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title_fullStr | Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title_full_unstemmed | Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title_short | Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro |
title_sort | bone protective effects of danggui buxue tang alone and in combination with tamoxifen or raloxifene in vivo and in vitro |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099153/ https://www.ncbi.nlm.nih.gov/pubmed/30150931 http://dx.doi.org/10.3389/fphar.2018.00779 |
work_keys_str_mv | AT zhouliping boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT wongkaying boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT yeunghoiting boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT dongxiaoli boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT xiaohuihui boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT gongamygw boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT tsimkarlwk boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro AT wongmansau boneprotectiveeffectsofdangguibuxuetangaloneandincombinationwithtamoxifenorraloxifeneinvivoandinvitro |